Adirondack Trust Company’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2K | Hold |
925
| – | – | ﹤0.01% | 345 |
|
|
2025
Q1 | $13.3K | Hold |
925
| – | – | 0.01% | 326 |
|
|
2024
Q4 | $15.5K | Hold |
925
| – | – | 0.01% | 320 |
|
|
2024
Q3 | $14.8K | Hold |
925
| – | – | 0.01% | 331 |
|
|
2024
Q2 | $8.35K | Hold |
925
| – | – | ﹤0.01% | 375 |
|
|
2024
Q1 | $10.5K | Hold |
925
| – | – | ﹤0.01% | 355 |
|
|
2023
Q4 | $9.72K | Hold |
925
| – | – | ﹤0.01% | 358 |
|
|
2023
Q3 | $5.98K | Hold |
925
| – | – | ﹤0.01% | 395 |
|
|
2023
Q2 | $7.31K | Hold |
925
| – | – | ﹤0.01% | 363 |
|
|
2023
Q1 | $3.56K | Hold |
925
| – | – | ﹤0.01% | 422 |
|
|
2022
Q4 | $2.86K | Hold |
925
| – | – | ﹤0.01% | 426 |
|
|
2022
Q3 | $4K | Hold |
925
| – | – | ﹤0.01% | 408 |
|
|
2022
Q2 | $5K | Hold |
925
| – | – | ﹤0.01% | 378 |
|
|
2022
Q1 | $8K | Buy |
925
+525
| +131% | +$4.54K | ﹤0.01% | 338 |
|
|
2021
Q4 | $5K | Buy |
+400
| New | +$5K | ﹤0.01% | 347 |
|